BOLD - Audentes Therapeutics - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

with an average price target of $18.7. This is a potential upside of $8.14 (77.08%) from yesterday's end of day stock price of $10.56.

Audentes Therapeutics's activity chart (see below) currently has 27 price targets and 18 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 97.22% with an average time for these price targets to be met of 208 days.

Most recent stock forecast was given by JOSEPH SCHWARTZ from LEERINK on 04-Dec-2019. First documented stock forecast 01-May-2017.

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

48

4 years 4 months 16 days ago

4/4 (100%)

$9.47 (24.58%)

224

Hold

45

4 years 4 months 17 days ago

4/4 (100%)

$8.67 (23.86%)

290

Buy

55

4 years 4 months 17 days ago

9/9 (100%)

$26.55 (93.32%)

264

Hold

48

4 years 4 months 17 days ago

7/7 (100%)

$7.87 (19.61%)

90

Hold

57

4 years 4 months 17 days ago

2/2 (100%)

$17.02 (43.32%)

468

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is BOLD (Audentes Therapeutics) average time for price targets to be met?

On average it took 208 days on average for the stock forecasts to be realized with a an average price target met ratio 97.22

Which analyst has the current highest performing score on BOLD (Audentes Therapeutics) with a proven track record?

DAVID NIERENGARTEN

Which analyst has the current lower performing score on BOLD (Audentes Therapeutics) with a proven track record?

MOHIT BANSAL

Which analyst has the most public recommendations on BOLD (Audentes Therapeutics)?

David Nierengarten works at WEDBUSH and has 5 price targets and 3 ratings on BOLD

Which analyst is the currently most bullish on BOLD (Audentes Therapeutics)?

Mohit Bansal with highest potential upside - $0.03

Which analyst is the currently most reserved on BOLD (Audentes Therapeutics)?

Joshua Schimmer with lowest potential downside - -$19.97

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?